Longevity Health (NASDAQ:XAGE) Stock Price Down 4.1% – Should You Sell?

Longevity Health Holdings, Inc. (NASDAQ:XAGE) dropped 4.1% during trading on Thursday . The company traded as low as $0.26 and last traded at $0.2810. Approximately 5,139 shares changed hands during mid-day trading, an increase of 83% from the average daily volume of 2,808 shares. The stock had previously closed at $0.2929.

Longevity Health Stock Down 4.1%

The firm has a 50-day moving average of $0.31 and a 200 day moving average of $0.46. The stock has a market capitalization of $500,742.00, a P/E ratio of -0.06 and a beta of 0.37.

Longevity Health Company Profile

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.